Peripheral neuropathies and anti-glycolipid antibodies.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Brain : a journal of neurology

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/BRAIN/AWF272PMID 12429589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier

  2004cited by this paper
• Anti-GT1a IgG in Guillain-Barré syndrome

  2002cited by this paper
• Localization of major gangliosides in the PNS: implications for immune neuropathies.

  2002cited by this paper
• Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome.

  2002cited by this paper
• Intravenous immunoglobulin therapy for Guillain–Barré syndrome with IgG anti‐GM1 antibody

  2001cited by this paper
• Guillain–Barré syndrome associated with IgG monospecific to ganglioside GD1b

  2001cited by this paper
• Bickerstaff's encephalitis and the Miller Fisher syndrome

  2001cited by this paper
• Anti-GQ1b IgG antibody syndrome: clinical and immunological range

  2001cited by this paper
• Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies.

  2001cited by this paper
• The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies.

  2001influential reference
• Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.

  2001cited by this paper
• Variants of the Guillain Barré syndrome: Progress Toward Fulfilling “Koch's postulates”

  2001cited by this paper
• Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.

  2001cited by this paper
• Miller Fisher syndrome and Haemophilus influenzae infection

  2001cited by this paper
• Animal model of axonal Guillain‐Barré syndrome induced by sensitization with GM1 ganglioside

  2001cited by this paper
• Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal.

  2001cited by this paper
• Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features.

  2001cited by this paper
• Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

  2001influential reference
• Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry

  2001influential reference
• Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies.

  2000cited by this paper
• Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan

  2000influential reference
• Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barré syndrome

  2000cited by this paper
• T-Independent immune response: new aspects of B cell biology.

  2000cited by this paper
• Haemophilus influenzae infection and Guillain-Barré syndrome.

  2000cited by this paper
• Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.

  2000cited by this paper
• Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody

  2000cited by this paper
• Peripheral Neuropathy Associated with Anti-GM2 Ganglioside Antibodies: Clinical and Immunopathological Studies

  2000influential reference
• Long‐term clinical and neurophysiological follow‐up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy

  2000cited by this paper
• Anti-PMP22 antibodies in patients with inflammatory neuropathy.

  2000cited by this paper
• Campylobacter jejuni infection and Guillain-Barré syndrome.

  2000influential reference
• Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies.

  2000cited by this paper
• Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.

  2000cited by this paper
• Clinical features and response to treatment in Guillain‐Barré syndrome associated with antibodies to GM1b ganglioside

  2000cited by this paper
• Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: Relation to Miller Fisher syndrome

  2000cited by this paper
• Subtle brain abnormalities in children with sickle cell disease: Relationship to blood hematocrit

  2000cited by this paper
• Ataxic form of Guillain-Barr syndrome associated with anti-GD1b IgG antibody.

  2000cited by this paper
• Rabbit experimental sensory ataxic neuropathy: anti-GD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons.

  1999cited by this paper
• Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection

  1999cited by this paper
• Antibodies to GD3, GT3, and O-acetylated species in Guillain-Barré and Fisher's syndromes: their association with cranial nerve dysfunction.

  1999cited by this paper
• Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom

  1999cited by this paper
• Prevalence of epilepsy in rural Bolivia

  1999cited by this paper
• Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain–Barré syndrome

  1999cited by this paper
• The distribution of ganglioside-like moieties in peripheral nerves.

  1999cited by this paper
• Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates.

  1999cited by this paper
• Paraproteinaemic Neuropathies

  1999cited by this paper
• Pathogenesis of Guillain-Barré syndrome.

  1999influential reference
• Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile.

  1999cited by this paper
• Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block.

  1999cited by this paper
• Anti‐GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia

  1999influential reference
• Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.

  1999influential reference
• Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases.

  1999cited by this paper
• The immunopathogenesis of Miller Fisher syndrome.

  1999cited by this paper
• IgG anti-GQ1b positive acute ataxia without ophthalmoplegia

  1999cited by this paper
• Cytomegalovirus is not associated with IgM anti–myelin‐associated glycoprotein/sulphate‐3‐glucuronyl paragloboside antibody–associated neuropathy

  1999cited by this paper
• Anti‐GalNAc‐GD1a antibody–associated Guillain‐Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance

  1999cited by this paper
• Inter‐laboratory validation of an ELISA for the determination of serum anti‐ganglioside antibodies

  1999cited by this paper
• Autoantibodies associated with peripheral neuropathy

  1999cited by this paper
• Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates

  1999influential reference
• Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China.

  1999cited by this paper
• Fisher Syndrome with tetraparesis and antibody to GQ1b: Evidence for motor nerve terminal block

  1999cited by this paper
• Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome.

  1999cited by this paper
• Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum.

  1999influential reference
• Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis

  1999cited by this paper
• Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome

  1999cited by this paper
• Monospecific anti‐GD1b IgG is required to induce rabbit ataxic neuropathy

  1999influential reference
• IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab

  1999cited by this paper
• Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.

  1998cited by this paper
• IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndrome

  1998influential reference
• Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies.

  1998cited by this paper
• The Role of Glycosphinglipids in Neurological Disorders: Mechanisms of Immune Action a

  1998cited by this paper
• Guillain-Barré syndrome associated with IgG anti-GM1b antibody subsequent to Mycoplasma pneumoniae infection.

  1998cited by this paper
• Gangliosides and Glycosphingolipids of Peripheral Nervous System Myelins—a Minireview

  1998influential reference
• The spectrum of antecedent infections in Guillain-Barré syndrome

  1998cited by this paper
• Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?

  1998cited by this paper
• Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.

  1998cited by this paper
• Correlation between cytomegalovirus infection and IgM anti‐MAG/SGPG antibody–associated neuropathy

  1998cited by this paper
• Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome

  1998influential reference
• Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody

  1998influential reference
• Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals

  1998cited by this paper
• Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M‐protein antibody activity and clinical/electrophysiological features in 40 cases

  1998influential reference
• IgG Anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

  1998cited by this paper
• Acute isolated ophthalmoplegia as a variant of Miller–Fisher syndrome

  1998cited by this paper
• Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992–3: incidence, clinical features, and prognosis

  1998cited by this paper
• Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barré Syndrome Exhibit Mimicry of GM1 Ganglioside

  1998cited by this paper
• Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies

  1998cited by this paper
• Acute cytomegalovirus infection and IgM anti-GM2 antibody.

  1998influential reference
• Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy.

  1998cited by this paper
• Functional rafts in cell membranes

  1997cited by this paper
• Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after campylobacter infection

  1997influential reference
• TLC blotting: application to microscale analysis of lipids and as a new approach to lipid-protein interaction.

  1997cited by this paper
• A monoclonal antibody that recognizes ganglioside GD1b in the rat central nervous system.

  1997cited by this paper
• Clinical and epidemiologic features of Guillain-Barré syndrome.

  1997cited by this paper
• Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy.

  1997influential reference
• The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.

  1997cited by this paper
• Association between Campylobacter infection and Guillain-Barré syndrome.

  1997cited by this paper
• Electrodiagnostic findings related to anti‐GM1 and anti‐GQ1b antibodies in Guillain‐Barré syndrome

  1997influential reference
• Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides.

  1997influential reference
• Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.

  1997cited by this paper
• Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins.

  1997cited by this paper
• Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain‐Barré syndrome and Fisher's syndrome

  1997influential reference

• Intravenous immunoglobulin use in neurology.

  2026cites this paper
• Case Report: Anti-GT1a antibody-associated ocular flutter

  2026cites this paper
• Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathies.

  2026cites this paper
• Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS neurologic diseases.

  2026cites this paper
• Guillain-Barré syndrome after the Zika epidemic in Colombia: A multicenter, matched case-control study

  2025cites this paper
• Multifocal Motor Neuropathy: A Narrative Review

  2025cites this paper
• Guillain–Barré syndrome and albuminocytological dissociation: a narrative review

  2025cites this paper
• Sulfatide antibody-mediated neuropathy: an analysis of clinical characteristics and immunotherapeutic responses

  2025cites this paper
• Miller-Fisher syndrome subtype with isolated bilateral mydriasis: a pediatric case report

  2025cites this paper
• Beyond the Toll‐Like Receptor 4. Structure‐Dependent Lipopolysaccharide Recognition Systems: How far are we?

  2025cites this paper
• Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome

  2025cites this paper
• A Rare Guillain-Barré Syndrome Variant with Multi-Ganglioside Reactivity: A Case of Severe Cranial Nerve Involvement

  2025cites this paper
• Lymphoplasmapheresis for Steroid‐Refractory Neuromyelitis Optica Spectrum Disorder: A Real‐World Multicenter Study in China

  2025cites this paper
• Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies

  2025cites this paper
• IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset

  2024cites this paper
• Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis

  2024cites this paper
• Neuropathies motrices multifocales avec bloc de conduction

  2024cites this paper
• Campylobacter jejuni/coli Infection: Is It Still a Concern?

  2024cites this paper
• Loss of Fine Motor Dexterity and Reduced Oral Hygiene 15 Years After Diagnosis of Multifocal Motor Neuropathy with Screw-Retained Implant-Supported Rehabilitation: Literature Review and Case Report

  2024cites this paper
• Optimization of serum samples derivatization process by I-Optimal Split-plot design of experiments for GC–MS metabolomics of inflammatory neuropathies

  2024cites this paper
• Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndrome

  2024cites this paper
• Neuropatie motorie multifocali con blocco di conduzione

  2024cites this paper
• Unraveling the complexity of glycosphingolipidome: the key role of mass spectrometry in the structural analysis of glycosphingolipids

  2024cites this paper
• Critical Care in Guillain–Barré Syndrome

  2024cites this paper
• Antibodies in immune-mediated peripheral neuropathies. Where are we in 2024?

  2024cites this paper
• Guillain–Barré syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features

  2024cites this paper
• Recent Advances, Challenges, and Future Directions in the Mass Spectrometry Analysis of Glycosphingolipids in Biological Samples

  2024cites this paper
• Siponimod ameliorates experimental autoimmune neuritis

  2023cites this paper
• Clinical Accent and Outcomes of the Guillain - Barre Syndrome (Acute Inflammatory Demyelinating Polyradiculoneuropathy)

  2023cites this paper
• Polyradiculonévrite aiguë démyélinisante, ou syndrome de Guillain-Barré

  2023cites this paper
• Frequency, Age, Gender Distribution, and Seasonal Variation of Guillain-Barré Syndrome in a Province of Pakistan: A Retrospective Study

  2023cites this paper
• Clinical Features and Neurotologic Findings in Patients With Acute Unilateral Peripheral Vestibulopathy Associated With Antiganglioside Antibody

  2023cites this paper
• Synergistic effects of immune checkpoints and checkpoint inhibitors in inflammatory neuropathies: Implications and mechanisms

  2023cites this paper
• Cell density-dependent membrane distribution of ganglioside GM3 in melanoma cells

  2023cites this paper
• Poliradicoloneurite acuta demielinizzante o sindrome di Guillain-Barré

  2023cites this paper
• Convolution Neural Network and EVO Based Efficient Method for Detecting Nerve Disorders

  2023cites this paper
• Immune-Mediated Neuropathies: Pathophysiology and Management

  2023cites this paper
• Guillain-Barre syndrome following COVID-19 vaccines: A review of literature

  2023cites this paper
• Sialic acids in infection and their potential use in detection and protection against pathogens

  2023cites this paper
• Kinetics of Ganglioside-Rich Supported Lipid Bilayer Formation with Tracer Vesicle Fluorescence Imaging.

  2023cites this paper
• Acute/chronic inflammatory polyradiculoneuropathy.

  2023cites this paper
• Anti-GT1a and anti-GQ1b immunoglobulin G antibody positivity with overlapping Miller Fisher/Guillain–Barré syndromes and prominent headache: a case report

  2023cites this paper
• Atypical chronic inflammatory demyelinating polyradiculoneuropathy with ophthalmoplegia and anti-sulfatide IgM positivity

  2023cites this paper
• Progress in Guillain–Barré syndrome immunotherapy—A narrative review of new strategies in recent years

  2023cites this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus - treatment with intravenous immunoglobulins: A systematic review.

  2023cites this paper
• Síndrome de Guillain Barre, más que un trastorno motor: análisis de 20 casos con afectación del nervio vestibulococlear

  2023cites this paper
• Polirradiculoneuritis aguda desmielinizante o síndrome de Guillain-Barré

  2023cites this paper
• Early Disability Predictors of Guillain–Barre Syndrome

  2022cites this paper
• EREDETI KÖZLEMÉNY INVESTIGATION OF OXIDATIVE STRESS IN PATIENTS WITH MULTIFOCAL MOTOR NEUROPATHY

  2022cites this paper
• Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats

  2022cites this paper
• Nationwide survey of childhood Guillain-Barré syndrome, Fisher syndrome, and Bickerstaff brainstem encephalitis in Japan.

  2022cites this paper
• Anti‐disialosyl‐immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study

  2022cites this paper
• A first case of childhood chronic inflammatory demyelinating polyneuropathy associated with alopecia universalis.

  2022cites this paper
• Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials

  2022cites this paper
• Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases

  2022cites this paper
• Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature

  2022cites this paper
• Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients.

  2022cites this paper
• [Pathophysiological and diagnostic aspects of Guillain-Barré syndrome].

  2022cites this paper
• Guillain-Barré syndrome: expanding the concept of molecular mimicry.

  2022cites this paper
• Immunoglobulin for multifocal motor neuropathy.

  2022cites this paper
• Treatment and Management of Autoimmune Neuropathies

  2022cites this paper
• Neurosurgical Mimics.

  2022cites this paper
• Campylobacter jejuni and Postinfectious Autoimmune Diseases: A Proof of Concept in Glycobiology.

  2022cites this paper
• Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine

  2021cites this paper
• Anti-glycan antibodies: roles in human disease.

  2021cites this paper
• Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review

  2021cites this paper
• Unclassified subtype of Guillain-Barré syndrome is associated with quick recovery.

  2021cites this paper
• Acute and Chronic Immune Neuropathies and Radiculopathies

  2021cites this paper
• A 50-Year-Old Patient with Guillain–Barré Syndrome after COVID-19: A Case Report

  2021cites this paper
• The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System

  2021cites this paper
• High-resolution mapping identifies HLA class II associations with multifocal motor neuropathy.

  2021cites this paper
• Glycan Arrays: Construction, Detection, and Analysis

  2021cites this paper
• The role of antibodies to peripheral nerve antigens in pathogenesis and laboratory evaluation of immune-mediated neuropathies

  2021cites this paper
• Chronic Immune-Mediated Polyneuropathies.

  2021cites this paper
• Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

  2021influential citation
• Immune-mediated ophthalmoparesis with anti-GD1a antibodies

  2021cites this paper
• The role of gangliosides in the organisation of the node of Ranvier examined in glycosyltransferase transgenic mice

  2021cites this paper
• Dinutuximab beta‐related severe neurotoxicity: Resolution with the use of plasmapheresis

  2021cites this paper
• Neuronally expressed a‐series gangliosides are sufficient to prevent the lethal age‐dependent phenotype in GM3‐only expressing mice

  2021cites this paper
• Mannose-binding lectin promotes blood-brain barrier breakdown and exacerbates axonal damage after traumatic brain injury in mice.

  2021cites this paper
• Primary Cilia in Glial Cells: An Oasis in the Journey to Overcoming Neurodegenerative Diseases

  2021cites this paper
• Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritis.

  2021cites this paper
• Siglecs at the Host–Pathogen Interface

  2020cites this paper
• GalCer: Galactocerebroside GBS: Guillain-Barré syndrome IMPN: Immune-mediated polyneurop- athy IVIg: Intravenous immunoglobulin MAG: Myelin-associated glycoprotein MFS: Miller Fisher syndrome MMN: Multifocal motor neuropathy PCB: Pharyngeal-cervical brachial variant of GBS Autoimmune Peripheral Neu

  2020cites this paper
• Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline.

  2020cites this paper
• Acute motor axonal neuropathy

  2020influential citation
• Lectin in Host Defense Against Microbial Infections

  2020cites this paper
• Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program

  2020cites this paper
• Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing

  2020cites this paper
• Histological and Clinical Findings in Rabbits Sensitized with GM1 Ganglioside

  2020cites this paper
• Toxemia in Human Naturally Acquired Botulism

  2020cites this paper
• Trauma-Related Guillain–Barré Syndrome: Systematic Review of an Emerging Concept

  2020cites this paper
• Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders

  2020cites this paper
• Nervous System Sampling for General Toxicity and Neurotoxicity Studies in Rabbits

  2020cites this paper
• Surge of Miller Fisher variant and Guillain‐Barré syndrome in two downtown Los Angeles community teaching hospitals

  2020cites this paper
• Guillain-Barré Syndrome.

  2020cites this paper
• Guillain-Barré syndrome after COVID-19 in Japan

  2020cites this paper
• Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients

  2020cites this paper
• Peripheral Neuropathies

  2020cites this paper
• Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome

  2020cites this paper